An2 Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $311k | 64k | 4.84 |
| 2023-03-31 | $295k | 30k | 9.87 |
| 2022-12-31 | $237k | 25k | 9.53 |
| 2022-09-30 | $178k | 10k | 17.47 |
| 2022-06-30 | $79k | 10k | 7.75 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management